Delving into the intricate landscape of prostate cancer diagnostics, understanding the roles of germline testing and tumor testing is paramount. At the prestigious ESMO Congress 2023, Oncology Frontier had the honor of hosting Professor Kim Nguyen N. Chi, an esteemed expert in the field, to shed light on these pivotal aspects. In this discussion, we’ll explore the distinctive roles of germline and tumor testing in the context of prostate cancer, drawing from the insights shared by Professor Chi during this exclusive event.
